Anti-RSV Study in Chinese Patients (ASCENT)

Clinical trial NCT03699202 · TERMINATED

Trial details

NCT number: NCT03699202
Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2019-03-28
Primary completion: 2019-04-04
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.